Once a covered equity is enrolled in the 340B Program and included in the 340B OPAIS, it is the covered entity's responsibility to inform wholesalers and manufacturers of enrollment in order to purchase drugs at the 340B discounted price.
Covered entities may continue to work directly with individual wholesalers and manufacturers and may participate in the 340B Prime Vendor Program (PVP).
340B covered entities should follow reimbursement terms in their contracts with payers. Medicaid has special requirements; for additional information, see the Medicaid topic.
Click here to view all on this subject